Onderneming Taysha Gene Therapies, Inc.
Aandelen
TSHA
US8776191061
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,58 USD | +6,61% | +12,17% | +45,76% |
Vakgebied
Aantal werknemers: 52
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Adeno-Associated Viruses-based Gene Therapies
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 01-08-20 |
President | 58 | 01-07-20 | |
Fred Porter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jim Rouse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sean McAuliffe
PRN | Corporate Officer/Principal | - | 01-06-20 |
Emily McGinnis
LAW | General Counsel | - | 01-04-20 |
Tracy M. Porter
HRO | Human Resources Officer | - | 26-01-21 |
Mary Newman
PRN | Corporate Officer/Principal | 65 | 13-05-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 31-08-20 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Sean Stalfort
BRD | Director/Board Member | 54 | 21-06-23 |
President | 58 | 01-07-20 | |
Director/Board Member | 63 | 23-11-20 | |
Alison Long
BRD | Director/Board Member | - | 01/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 187 018 275 | 140 693 475 ( 75,23 %) | 0 | 75,23 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,76% | 483 mln. | |
+26,28% | 48,09 mld. | |
-3,99% | 40,43 mld. | |
+46,79% | 40,62 mld. | |
-6,20% | 28,36 mld. | |
+6,36% | 24,89 mld. | |
-21,47% | 19,01 mld. | |
+27,58% | 12,09 mld. | |
-2,75% | 11,8 mld. | |
-2,02% | 11,88 mld. |
- Beurs
- Aandelen
- Koers TSHA
- Onderneming Taysha Gene Therapies, Inc.